Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “breast cancer”
Sponsor: Spanish Breast Cancer Research Group
Early-stage Breast Cancer
Spain
- Analysis of Breath Volatile Organic Compounds Using Mass SpectrometryNot Yet Recruiting
Sponsor: University of Oklahoma
Pancreas Cancer · Hepatocellular Carcinoma · Lung Cancer · Ovarian Cancer
United States
- Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor TherapyNot Yet Recruiting
Sponsor: Duke University
Breast Cancer, Hormone Receptor Positive, Aromatase Inhibitor-Associated Arthralgia
- PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBCActive Not Recruiting
Sponsor: Biotheus Inc.
Triple Negative Breast Cancer(TNBC)
China
Sponsor: UNC Lineberger Comprehensive Cancer Center
Breast Cancer · Relapse · Resistant Cancer · Triple Negative Breast Cancer
United States
Sponsor: Novartis Pharmaceuticals
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) · Non-small Cell Lung Cancer (NSCLC) · HR+/HER2- Ductal Breast Cancer (BC) · HR+/HER2- Lobular Breast Cancer (BC)
Japan
Sponsor: Novartis Pharmaceuticals
Breast Cancer · Non-small Cell Lung Cancer (NSCLC) · Gastric/Gastroesophageal Junction (GEJ) Cancer · Bladder Cancer
United States, Australia, Canada, Japan
- Social Media-Based Education on Cancer Screening Awareness in Women: A Randomized Controlled TrialCompleted
Sponsor: Emine Ergin
Cervical Cancer Screening · Breast Cancer Screening · Colorectal Cancer Screening · Digital Health Literacy
Turkey (Türkiye)
Sponsor: Compass Therapeutics
Non Small Cell Lung Cancer · Triple Negative Breast Cancer · Hodgkin Lymphoma · Head and Neck Squamous Cell Carcinoma
United States
- Exercise Intervention for Breast Cancer Patients With SarcopeniaNot Yet Recruiting
Sponsor: Capital Medical University
Sarcopenia · Breast Cancer
China
Sponsor: Vironexis Biotherapeutics Inc.
HER2 Expressing Solid Tumors
United States
- Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.Active Not Recruiting
Sponsor: Taiho Oncology, Inc.
Advanced/Metastatic Cancer
United States, France, South Korea, Spain, United Kingdom
- BRCA Mutations in LatinasCompleted
Sponsor: National Cancer Institute (NCI)
Breast Neoplasms
United States
Sponsor: Hacettepe University
Breast Cancer · Chemotherapy
Turkey (Türkiye)
Sponsor: Spectrum Pharmaceuticals, Inc
NSCLC · Breast Cancer
United States
Sponsor: Columbia University
Breast Cancer
United States
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Triple-Negative Breast Cancer (TNBC)
China
Sponsor: University of Alabama at Birmingham
Breast Cancer
Sponsor: Fore Biotherapeutics
Cancer Harboring BRAF Alterations · HGG · LGG · Solid Tumors
United States, Australia, Canada, France, Germany +7 more
Sponsor: Puma Biotechnology, Inc.
Hormone Receptor Positive HER-2 Negative Breast Cancer · Metastatic Breast Cancer · Recurrent Breast Cancer
United States, Portugal, Spain
- Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast CancerCompleted
Sponsor: MedSIR
Breast Cancer · Triple Negative Breast Cancer
Spain
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Argentina, Australia, Belgium, Brazil +24 more
Sponsor: Washington University School of Medicine
Breast Cancer · Cancer of Breast · Breast Neoplasms · Cancer of the Breast
United States
- Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT).Not Yet Recruiting
Sponsor: University of Arizona
Breast Cancer Detection
Sponsor: University of Nottingham
Breast Cancer Female
United Kingdom